> top > docs > PubMed:17959715 > annotations

PubMed:17959715 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
4453 12-16 GeneOrGeneProduct denotes MLH1 NCBIGene:4292
4454 29-35 DiseaseOrPhenotypicFeature denotes cancer MESH:D009369
4455 71-87 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma MESH:D006689
4456 172-188 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma MESH:D006689
4457 248-255 DiseaseOrPhenotypicFeature denotes cancers MESH:D009369
4458 257-269 DiseaseOrPhenotypicFeature denotes Cytotoxicity MESH:D064420
4459 363-367 GeneOrGeneProduct denotes MLH1 NCBIGene:4292
4460 427-436 DiseaseOrPhenotypicFeature denotes cytotoxic MESH:D064420
4461 614-618 GeneOrGeneProduct denotes MLH1 NCBIGene:4292
4462 634-643 SequenceVariant denotes rs1800734 DBSNP:rs1800734
4463 666-672 DiseaseOrPhenotypicFeature denotes cancer MESH:D009369
4464 718-726 OrganismTaxon denotes patients NCBITaxon:9606
4465 741-747 DiseaseOrPhenotypicFeature denotes cancer MESH:D009369
4466 806-814 OrganismTaxon denotes patients NCBITaxon:9606
4467 838-855 DiseaseOrPhenotypicFeature denotes myeloid leukaemia MESH:D007938
4468 861-869 OrganismTaxon denotes patients NCBITaxon:9606
4469 885-909 DiseaseOrPhenotypicFeature denotes primary Hodgkin lymphoma MESH:D006689
4470 960-964 GeneOrGeneProduct denotes MLH1 NCBIGene:4292
4471 1137-1143 DiseaseOrPhenotypicFeature denotes cancer MESH:D009369
4472 1152-1156 GeneOrGeneProduct denotes MLH1 NCBIGene:4292
4473 1338-1342 GeneOrGeneProduct denotes MLH1 NCBIGene:4292
4474 1369-1377 OrganismTaxon denotes patients NCBITaxon:9606
4475 1408-1431 DiseaseOrPhenotypicFeature denotes acute myeloid leukaemia MESH:D015470
4476 1435-1438 DiseaseOrPhenotypicFeature denotes AML MESH:D015470
4477 1459-1472 DiseaseOrPhenotypicFeature denotes breast cancer MESH:D001943
4478 1524-1540 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma MESH:D006689
4479 1553-1561 OrganismTaxon denotes patients NCBITaxon:9606
4480 1603-1606 DiseaseOrPhenotypicFeature denotes AML MESH:D015470
4481 1623-1636 DiseaseOrPhenotypicFeature denotes breast cancer MESH:D001943
4482 1637-1645 OrganismTaxon denotes patients NCBITaxon:9606
4483 1667-1671 GeneOrGeneProduct denotes MLH1 NCBIGene:4292
4484 1722-1725 DiseaseOrPhenotypicFeature denotes AML MESH:D015470
4485 1757-1760 DiseaseOrPhenotypicFeature denotes AML MESH:D015470
4486 1894-1897 DiseaseOrPhenotypicFeature denotes AML MESH:D015470
4487 1968-1976 OrganismTaxon denotes patients NCBITaxon:9606
4488 2138-2142 GeneOrGeneProduct denotes MLH1 NCBIGene:4292
4489 2188-2194 DiseaseOrPhenotypicFeature denotes cancer MESH:D009369
4490 2230-2246 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma MESH:D006689

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-88 Sentence denotes Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.
T2 89-114 Sentence denotes BACKGROUND AND OBJECTIVE:
T3 115-256 Sentence denotes Methylating agents are effective chemotherapy agents for Hodgkin lymphoma, but are associated with the development of second primary cancers.
T4 257-354 Sentence denotes Cytotoxicity of methylating agents is mediated primarily by the DNA mismatch repair (MMR) system.
T5 355-545 Sentence denotes Loss of MLH1, a major component of DNA MMR, results in tolerance to the cytotoxic effects of methylating agents and persistence of mutagenised cells at high risk of malignant transformation.
T6 546-704 Sentence denotes We hypothesised that a common substitution in the basal promoter of MLH1 (position -93, rs1800734) modifies the risk of cancer after methylating chemotherapy.
T7 705-713 Sentence denotes METHODS:
T8 714-1091 Sentence denotes 133 patients who developed cancer following chemotherapy and/or radiotherapy (n = 133), 420 patients diagnosed with de novo myeloid leukaemia, 242 patients diagnosed with primary Hodgkin lymphoma, and 1177 healthy controls were genotyped for the MLH1 -93 polymorphism by allelic discrimination polymerase chain reaction (PCR) and restriction fragment length polymorphism assay.
T9 1092-1303 Sentence denotes Odds ratios and 95% confidence intervals for cancer risk by MLH1 -93 polymorphism status, and stratified by previous exposure to methylating chemotherapy, were calculated using unconditional logistic regression.
T10 1304-1312 Sentence denotes RESULTS:
T11 1313-1662 Sentence denotes Carrier frequency of the MLH1 -93 variant was higher in patients who developed therapy related acute myeloid leukaemia (t-AML) (75.0%, n = 12) or breast cancer (53.3%. n = 15) after methylating chemotherapy for Hodgkin lymphoma compared to patients without previous methylating exposure (t-AML, 30.4%, n = 69; breast cancer patients, 27.2%, n = 22).
T12 1663-2021 Sentence denotes The MLH1 -93 variant allele was also over-represented in t-AML cases when compared to de novo AML cases (36.9%, n = 420) and healthy controls (36.3%, n = 952), and was associated with a significantly increased risk of developing t-AML (odds ratio 5.31, 95% confidence interval 1.40 to 20.15), but only in patients previously treated with a methylating agent.
T13 2022-2034 Sentence denotes CONCLUSIONS:
T14 2035-2247 Sentence denotes These data support the hypothesis that the common polymorphism at position -93 in the core promoter of MLH1 defines a risk allele for the development of cancer after methylating chemotherapy for Hodgkin lymphoma.
T15 2248-2316 Sentence denotes However, replication of this finding in larger studies is suggested.

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 29-35 DiseaseOrPhenotypicFeature denotes cancer 0004992
T2 71-87 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma 0004952
T3 79-87 DiseaseOrPhenotypicFeature denotes lymphoma 0005062
T4 172-188 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma 0004952
T5 180-188 DiseaseOrPhenotypicFeature denotes lymphoma 0005062
T6 248-255 DiseaseOrPhenotypicFeature denotes cancers 0004992
T7 666-672 DiseaseOrPhenotypicFeature denotes cancer 0004992
T8 741-747 DiseaseOrPhenotypicFeature denotes cancer 0004992
T9 893-909 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma 0004952
T10 901-909 DiseaseOrPhenotypicFeature denotes lymphoma 0005062
T11 1137-1143 DiseaseOrPhenotypicFeature denotes cancer 0004992
T12 1459-1472 DiseaseOrPhenotypicFeature denotes breast cancer 0007254
T13 1466-1472 DiseaseOrPhenotypicFeature denotes cancer 0004992
T14 1524-1540 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma 0004952
T15 1532-1540 DiseaseOrPhenotypicFeature denotes lymphoma 0005062
T16 1623-1636 DiseaseOrPhenotypicFeature denotes breast cancer 0007254
T17 1630-1636 DiseaseOrPhenotypicFeature denotes cancer 0004992
T18 2188-2194 DiseaseOrPhenotypicFeature denotes cancer 0004992
T19 2230-2246 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma 0004952
T20 2238-2246 DiseaseOrPhenotypicFeature denotes lymphoma 0005062

LitCoin-SeqVar

Id Subject Object Predicate Lexical cue
T1 634-643 SequenceVariant denotes rs1800734

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 12-16 GeneOrGeneProduct denotes MLH1
T2 295-303 GeneOrGeneProduct denotes mediated
T3 321-340 GeneOrGeneProduct denotes DNA mismatch repair
T4 363-367 GeneOrGeneProduct denotes MLH1
T5 371-376 GeneOrGeneProduct denotes major
T6 410-419 GeneOrGeneProduct denotes tolerance
T7 471-482 GeneOrGeneProduct denotes persistence
T8 498-503 GeneOrGeneProduct denotes cells
T9 507-511 GeneOrGeneProduct denotes high
T10 530-544 GeneOrGeneProduct denotes transformation
T11 614-618 GeneOrGeneProduct denotes MLH1
T12 705-712 GeneOrGeneProduct denotes METHODS
T13 857-860 GeneOrGeneProduct denotes 242
T14 960-964 GeneOrGeneProduct denotes MLH1
T15 1008-1018 GeneOrGeneProduct denotes polymerase
T16 1019-1024 GeneOrGeneProduct denotes chain
T17 1152-1156 GeneOrGeneProduct denotes MLH1
T18 1313-1320 GeneOrGeneProduct denotes Carrier
T19 1321-1330 GeneOrGeneProduct denotes frequency
T20 1338-1342 GeneOrGeneProduct denotes MLH1
T21 1433-1438 GeneOrGeneProduct denotes t-AML
T22 1448-1454 GeneOrGeneProduct denotes n = 12
T23 1601-1606 GeneOrGeneProduct denotes t-AML
T24 1654-1660 GeneOrGeneProduct denotes n = 22
T25 1667-1671 GeneOrGeneProduct denotes MLH1
T26 1720-1725 GeneOrGeneProduct denotes t-AML
T27 1726-1731 GeneOrGeneProduct denotes cases
T28 1761-1766 GeneOrGeneProduct denotes cases
T29 1817-1820 GeneOrGeneProduct denotes 952
T30 1892-1897 GeneOrGeneProduct denotes t-AML
T31 2121-2125 GeneOrGeneProduct denotes core
T32 2138-2142 GeneOrGeneProduct denotes MLH1
T33 2277-2284 GeneOrGeneProduct denotes finding

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 12-16 GeneOrGeneProduct denotes MLH1
T2 321-340 GeneOrGeneProduct denotes DNA mismatch repair
T3 363-367 GeneOrGeneProduct denotes MLH1
T4 371-376 GeneOrGeneProduct denotes major
T5 507-511 GeneOrGeneProduct denotes high
T6 614-618 GeneOrGeneProduct denotes MLH1
T7 960-964 GeneOrGeneProduct denotes MLH1
T8 1008-1018 GeneOrGeneProduct denotes polymerase
T9 1019-1024 GeneOrGeneProduct denotes chain
T10 1152-1156 GeneOrGeneProduct denotes MLH1
T11 1313-1320 GeneOrGeneProduct denotes Carrier
T12 1321-1330 GeneOrGeneProduct denotes frequency
T13 1338-1342 GeneOrGeneProduct denotes MLH1
T14 1667-1671 GeneOrGeneProduct denotes MLH1
T15 1817-1820 GeneOrGeneProduct denotes 952
T16 2121-2125 GeneOrGeneProduct denotes core
T17 2138-2142 GeneOrGeneProduct denotes MLH1

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 29-35 DiseaseOrPhenotypicFeature denotes cancer D009369
T2 71-87 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689
T3 172-188 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689
T4 233-255 DiseaseOrPhenotypicFeature denotes second primary cancers D016609
T5 257-269 DiseaseOrPhenotypicFeature denotes Cytotoxicity DISEASE
T6 427-436 DiseaseOrPhenotypicFeature denotes cytotoxic DISEASE
T7 520-529 DiseaseOrPhenotypicFeature denotes malignant D009369
T8 666-672 DiseaseOrPhenotypicFeature denotes cancer D009369
T9 741-747 DiseaseOrPhenotypicFeature denotes cancer D009369
T10 893-909 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689
T11 1137-1143 DiseaseOrPhenotypicFeature denotes cancer D009369
T12 1459-1472 DiseaseOrPhenotypicFeature denotes breast cancer D001943
T13 1524-1540 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689
T14 1623-1636 DiseaseOrPhenotypicFeature denotes breast cancer D001943
T15 2188-2194 DiseaseOrPhenotypicFeature denotes cancer D009369
T16 2230-2246 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 12-16 GeneOrGeneProduct denotes MLH1
T2 321-340 GeneOrGeneProduct denotes DNA mismatch repair
T3 363-367 GeneOrGeneProduct denotes MLH1
T4 614-618 GeneOrGeneProduct denotes MLH1
T5 960-964 GeneOrGeneProduct denotes MLH1
T6 1152-1156 GeneOrGeneProduct denotes MLH1
T7 1338-1342 GeneOrGeneProduct denotes MLH1
T8 1667-1671 GeneOrGeneProduct denotes MLH1
T9 1817-1820 GeneOrGeneProduct denotes 952
T10 2138-2142 GeneOrGeneProduct denotes MLH1

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 71-87 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma 0004952
T2 172-188 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma 0004952
T3 893-909 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma 0004952
T4 1435-1438 DiseaseOrPhenotypicFeature denotes AML 0018874
T5 1459-1472 DiseaseOrPhenotypicFeature denotes breast cancer 0007254|0004989
T7 1524-1540 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma 0004952
T8 1603-1606 DiseaseOrPhenotypicFeature denotes AML 0018874
T9 1623-1636 DiseaseOrPhenotypicFeature denotes breast cancer 0007254|0004989
T11 1722-1725 DiseaseOrPhenotypicFeature denotes AML 0018874
T12 1757-1760 DiseaseOrPhenotypicFeature denotes AML 0018874
T13 1894-1897 DiseaseOrPhenotypicFeature denotes AML 0018874
T14 2230-2246 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma 0004952

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 29-35 DiseaseOrPhenotypicFeature denotes cancer D009369
T2 71-87 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689
T3 172-188 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689
T4 233-255 DiseaseOrPhenotypicFeature denotes second primary cancers D016609
T5 257-269 DiseaseOrPhenotypicFeature denotes Cytotoxicity DISEASE
T6 427-436 DiseaseOrPhenotypicFeature denotes cytotoxic DISEASE
T7 666-672 DiseaseOrPhenotypicFeature denotes cancer D009369
T8 741-747 DiseaseOrPhenotypicFeature denotes cancer D009369
T9 838-855 DiseaseOrPhenotypicFeature denotes myeloid leukaemia DISEASE
T10 893-909 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689
T11 1137-1143 DiseaseOrPhenotypicFeature denotes cancer D009369
T12 1408-1431 DiseaseOrPhenotypicFeature denotes acute myeloid leukaemia DISEASE
T13 1435-1438 DiseaseOrPhenotypicFeature denotes AML DISEASE
T14 1459-1472 DiseaseOrPhenotypicFeature denotes breast cancer D001943
T15 1524-1540 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689
T16 1603-1606 DiseaseOrPhenotypicFeature denotes AML DISEASE
T17 1623-1636 DiseaseOrPhenotypicFeature denotes breast cancer D001943
T18 1722-1725 DiseaseOrPhenotypicFeature denotes AML DISEASE
T19 1757-1760 DiseaseOrPhenotypicFeature denotes AML DISEASE
T20 1894-1897 DiseaseOrPhenotypicFeature denotes AML DISEASE
T21 2188-2194 DiseaseOrPhenotypicFeature denotes cancer D009369
T22 2230-2246 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 29-35 DiseaseOrPhenotypicFeature denotes cancer D009369
T2 71-87 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689
T3 172-188 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689
T4 233-255 DiseaseOrPhenotypicFeature denotes second primary cancers D016609
T5 257-269 DiseaseOrPhenotypicFeature denotes Cytotoxicity DISEASE
T6 427-436 DiseaseOrPhenotypicFeature denotes cytotoxic DISEASE
T7 666-672 DiseaseOrPhenotypicFeature denotes cancer D009369
T8 741-747 DiseaseOrPhenotypicFeature denotes cancer D009369
T9 838-855 DiseaseOrPhenotypicFeature denotes myeloid leukaemia DISEASE
T10 893-909 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689
T11 1137-1143 DiseaseOrPhenotypicFeature denotes cancer D009369
T12 1408-1431 DiseaseOrPhenotypicFeature denotes acute myeloid leukaemia DISEASE
T13 1435-1438 DiseaseOrPhenotypicFeature denotes AML DISEASE
T14 1459-1472 DiseaseOrPhenotypicFeature denotes breast cancer D001943
T15 1524-1540 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689
T16 1603-1606 DiseaseOrPhenotypicFeature denotes AML DISEASE
T17 1623-1636 DiseaseOrPhenotypicFeature denotes breast cancer D001943
T18 1722-1725 DiseaseOrPhenotypicFeature denotes AML DISEASE
T19 1757-1760 DiseaseOrPhenotypicFeature denotes AML DISEASE
T20 1894-1897 DiseaseOrPhenotypicFeature denotes AML DISEASE
T21 2188-2194 DiseaseOrPhenotypicFeature denotes cancer D009369
T22 2230-2246 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 718-726 OrganismTaxon denotes patients
T2 806-814 OrganismTaxon denotes patients
T3 861-869 OrganismTaxon denotes patients
T4 1369-1377 OrganismTaxon denotes patients
T5 1553-1561 OrganismTaxon denotes patients
T6 1637-1645 OrganismTaxon denotes patients
T7 1968-1976 OrganismTaxon denotes patients

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label
T10 2138-2142 GeneOrGeneProduct denotes MLH1
T9 1817-1820 GeneOrGeneProduct denotes 952
T8 1667-1671 GeneOrGeneProduct denotes MLH1
T7 1338-1342 GeneOrGeneProduct denotes MLH1
T6 1152-1156 GeneOrGeneProduct denotes MLH1
T5 960-964 GeneOrGeneProduct denotes MLH1
T4 614-618 GeneOrGeneProduct denotes MLH1
T3 363-367 GeneOrGeneProduct denotes MLH1
T2 321-340 GeneOrGeneProduct denotes DNA mismatch repair
T1 12-16 GeneOrGeneProduct denotes MLH1
T22 2230-2246 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689
T21 2188-2194 DiseaseOrPhenotypicFeature denotes cancer D009369
T20 1894-1897 DiseaseOrPhenotypicFeature denotes AML DISEASE
T19 1757-1760 DiseaseOrPhenotypicFeature denotes AML DISEASE
T18 1722-1725 DiseaseOrPhenotypicFeature denotes AML DISEASE
T17 1623-1636 DiseaseOrPhenotypicFeature denotes breast cancer D001943
T16 1603-1606 DiseaseOrPhenotypicFeature denotes AML DISEASE
T15 1524-1540 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689
T14 1459-1472 DiseaseOrPhenotypicFeature denotes breast cancer D001943
T13 1435-1438 DiseaseOrPhenotypicFeature denotes AML DISEASE
T12 1408-1431 DiseaseOrPhenotypicFeature denotes acute myeloid leukaemia DISEASE
T11 1137-1143 DiseaseOrPhenotypicFeature denotes cancer D009369
T10224 893-909 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689
T87984 838-855 DiseaseOrPhenotypicFeature denotes myeloid leukaemia DISEASE
T11181 741-747 DiseaseOrPhenotypicFeature denotes cancer D009369
T6765 666-672 DiseaseOrPhenotypicFeature denotes cancer D009369
T65917 427-436 DiseaseOrPhenotypicFeature denotes cytotoxic DISEASE
T95922 257-269 DiseaseOrPhenotypicFeature denotes Cytotoxicity DISEASE
T11067 233-255 DiseaseOrPhenotypicFeature denotes second primary cancers D016609
T2888 172-188 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689
T71713 71-87 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma D006689
T9623 29-35 DiseaseOrPhenotypicFeature denotes cancer D009369
T80947 1968-1976 OrganismTaxon denotes patients
T26614 1637-1645 OrganismTaxon denotes patients
T41113 1553-1561 OrganismTaxon denotes patients
T50663 1369-1377 OrganismTaxon denotes patients
T75296 861-869 OrganismTaxon denotes patients
T41344 806-814 OrganismTaxon denotes patients
T55653 718-726 OrganismTaxon denotes patients
T28006 634-643 SequenceVariant denotes rs1800734

PMID_GLOBAL

Id Subject Object Predicate Lexical cue mondo_id
T1 71-87 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma 0004952
T2 172-188 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma 0004952
T3 893-909 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma 0004952
T4 1435-1438 DiseaseOrPhenotypicFeature denotes AML 0018874
T5 1459-1472 DiseaseOrPhenotypicFeature denotes breast cancer 0004989|0007254
T7 1524-1540 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma 0004952
T8 1603-1606 DiseaseOrPhenotypicFeature denotes AML 0018874
T9 1623-1636 DiseaseOrPhenotypicFeature denotes breast cancer 0004989|0007254
T11 1722-1725 DiseaseOrPhenotypicFeature denotes AML 0018874
T12 1757-1760 DiseaseOrPhenotypicFeature denotes AML 0018874
T13 1894-1897 DiseaseOrPhenotypicFeature denotes AML 0018874
T14 2230-2246 DiseaseOrPhenotypicFeature denotes Hodgkin lymphoma 0004952

DisGeNET

Id Subject Object Predicate Lexical cue
T0 12-16 gene:4292 denotes MLH1
T1 71-87 disease:C0019829 denotes Hodgkin lymphoma
T2 12-16 gene:4292 denotes MLH1
T3 29-35 disease:C0006826 denotes cancer
T4 12-16 gene:4292 denotes MLH1
T5 29-35 disease:C1306459 denotes cancer
T6 614-618 gene:4292 denotes MLH1
T7 666-672 disease:C1306459 denotes cancer
T8 614-618 gene:4292 denotes MLH1
T9 666-672 disease:C0006826 denotes cancer
T10 1152-1156 gene:4292 denotes MLH1
T11 1137-1143 disease:C1306459 denotes cancer
T12 1152-1156 gene:4292 denotes MLH1
T13 1137-1143 disease:C0006826 denotes cancer
T14 1338-1342 gene:4292 denotes MLH1
T15 1459-1472 disease:C0678222 denotes breast cancer
T16 1338-1342 gene:4292 denotes MLH1
T17 1459-1472 disease:C0006142 denotes breast cancer
R1 T0 T1 associated_with MLH1,Hodgkin lymphoma
R2 T2 T3 associated_with MLH1,cancer
R3 T4 T5 associated_with MLH1,cancer
R4 T6 T7 associated_with MLH1,cancer
R5 T8 T9 associated_with MLH1,cancer
R6 T10 T11 associated_with MLH1,cancer
R7 T12 T13 associated_with MLH1,cancer
R8 T14 T15 associated_with MLH1,breast cancer
R9 T16 T17 associated_with MLH1,breast cancer

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 172-188 HP_0012189 denotes Hodgkin lymphoma
T2 180-188 HP_0002665 denotes lymphoma
T3 248-255 HP_0002664 denotes cancers
T4 666-672 HP_0002664 denotes cancer

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
17959715-0#12#16#gene4292 1152-1156 gene4292 denotes MLH1
17959715-0#71#87#diseaseC0019829 2230-2246 diseaseC0019829 denotes Hodgkin lymphoma
17959715-7#25#29#gene4292 1338-1342 gene4292 denotes MLH1
17959715-7#146#159#diseaseC0006142 1459-1472 diseaseC0006142 denotes breast cancer
17959715-7#146#159#diseaseC0678222 1459-1472 diseaseC0678222 denotes breast cancer
12#16#gene429271#87#diseaseC0019829 17959715-0#12#16#gene4292 17959715-0#71#87#diseaseC0019829 associated_with MLH1,Hodgkin lymphoma
25#29#gene4292146#159#diseaseC0006142 17959715-7#25#29#gene4292 17959715-7#146#159#diseaseC0006142 associated_with MLH1,breast cancer
25#29#gene4292146#159#diseaseC0678222 17959715-7#25#29#gene4292 17959715-7#146#159#diseaseC0678222 associated_with MLH1,breast cancer

tmVarCorpus

Id Subject Object Predicate Lexical cue
T1 634-643 SNP:rs1800734 denotes rs1800734